Porida generic name aliskirenzumab injection, is effective in lowering blood lipids, can be used in conjunction with other lipid-lowering therapies as prescribed by the doctor. The specific efficacy varies from person to person. 1. Aliskirenumab injection has lipid-lowering effects, and can be used alone or in combination with statins for adult patients diagnosed with atherosclerotic cardiovascular disease to reduce the risk of stroke, myocardial infarction, unstable angina; or with statins with or without other lipid-lowering therapies for the treatment of primary hypercholesterolemia and mixed dyslipidaemia, and so on. 2. The drug can mainly reduce LDL levels, resulting in a certain degree of lipid reduction, but due to individual variability, resulting in inconsistent lipid-lowering effect of the drug users. 3. Contraindications include known hypersensitivity to the drug and pregnant women. 4. The most common adverse reactions are local injection site reactions, upper respiratory signs and symptoms and pruritus, in addition to rare hypersensitivity reactions, allergic vasculitis, urticaria, coin-shaped eczema. Specific medication should be under the guidance of a specialist, not unauthorized use of medication.